Acorah Software Products - Accounts Production 16.1.300 false true 31 July 2023 1 August 2022 false true No description of principal activity 1 August 2023 31 July 2024 31 July 2024 08159598 Dr Fraz Younis iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08159598 2023-07-31 08159598 2024-07-31 08159598 2023-08-01 2024-07-31 08159598 frs-core:CurrentFinancialInstruments 2024-07-31 08159598 frs-bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 08159598 frs-bus:FilletedAccounts 2023-08-01 2024-07-31 08159598 frs-bus:Micro-entities 2023-08-01 2024-07-31 08159598 frs-bus:AuditExempt-NoAccountantsReport 2023-08-01 2024-07-31 08159598 frs-bus:Director1 2023-08-01 2024-07-31 08159598 2022-07-31 08159598 2023-07-31 08159598 2022-08-01 2023-07-31 08159598 frs-core:CurrentFinancialInstruments 2023-07-31
Registered number: 08159598
FY Medical Limited
Financial Statements
For The Year Ended 31 July 2024
Balance Sheet
Registered number: 08159598
2024 2023
£ £
Current assets 22,639 15,635
Creditors: Amounts Falling Due Within One Year (21,495 ) (15,308 )
NET CURRENT ASSETS 1,144 327
TOTAL ASSETS LESS CURRENT LIABILITIES 1,144 327
Accruals and deferred income (600 ) (600 )
NET ASSETS/(LIABILITIES) 544 (273 )
CAPITAL AND RESERVES 544 (273 )

Notes

1. General Information
FY Medical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 08159598 . The registered office is 58 Fenton street road, Rochdale, Lancashire, OL11 3TH.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
For the year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Fraz Younis
Director
21 March 2025